Distinguished in Age-Related Macular Degeneration (ARMD)

Albert J. Augustin

Lichtentaler Str. 13, 
Salem, BW, DE 
Distinguished in Age-Related Macular Degeneration (ARMD)
Lichtentaler Str. 13, 
Salem, BW, DE 
OverviewLocationsClinical Research

Overview

Albert Augustin practices in Salem, Germany. Mr. Augustin is rated as a Distinguished expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

His clinical research consists of co-authoring 53 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 34 articles in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

Lichtentaler Str. 13, Salem, BW 76530, Germany
Other Locations
Karlsruhe, BW 76133, Germany
Wuerzburg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Enrollment Status: Terminated
Publish Date: July 20, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Enrollment Status: Terminated
Publish Date: May 21, 2020
Argus II Retinal Prosthesis System - Better Vision RP Study
Argus II Retinal Prosthesis System - Better Vision RP Study
Enrollment Status: Withdrawn
Publish Date: June 25, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

53 Total Publications

Letter to the Editor Regarding "Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration".
Letter to the Editor Regarding "Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration".
Journal: Ophthalmology and therapy
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Augustin's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile